Biomarker: F007-IgE Oat

Overview

F007-IgE Oat measures immunoglobulin E (IgE) antibodies in blood that recognize oat proteins. IgE is involved in immediate hypersensitivity reactions by binding to mast cells and basophils, which can release inflammatory mediators after allergen exposure. A detectable or elevated result indicates sensitization to oat, but does not by itself confirm clinical oat allergy, predict reaction severity, or establish that oats caused symptoms. The test is clinically useful as part of an allergy-focused evaluation, interpreted with the patient’s history and, when necessary, a supervised oral food challenge.

Clinical Use Cases

Evaluation of suspected immediate hypersensitivity reactions after eating oats or oat-containing foods.
Identification of oat sensitization when skin-prick testing is unsuitable, including when antihistamines cannot be discontinued or extensive dermatitis is present.
Assessment of possible cereal-grain cross-reactivity in patients with IgE-mediated wheat allergy.
Supporting evaluation of food-related symptoms in patients with a relevant history, including hives, angioedema, respiratory symptoms, vomiting, or anaphylaxis.
Follow-up assessment when an allergist is determining whether sensitization may have changed over time.

Specimen Types

Venous whole blood, collected for laboratory processing.
Serum, the usual analytical matrix for allergen-specific IgE testing.
Plasma may be accepted by some assay platforms, according to laboratory requirements.

Measurement Methods

Solid-phase allergen-specific IgE immunoassay using an oat extract, commonly reported quantitatively in kUA/L.
Fluorescence enzyme immunoassay, including single-allergen assays.
Enzyme-linked immunosorbent assay, or ELISA.
Multiplex allergen microarray or component-based immunoassay, where available.
Immunoblotting or radioallergosorbent testing may be used in research or historical studies, but modern fluorescence-based assays have largely replaced RAST in routine testing.

Test Preparation and Influencing Factors

Fasting is generally not required for a blood-specific IgE test.
Tell the healthcare provider about all medications and supplements. Do not stop antihistamines or other medicines unless specifically instructed.
Results should be interpreted with the timing, amount, and form of oat exposure and the symptoms that followed.
A positive result may represent sensitization without clinical allergy, including possible cross-reactivity with related cereal allergens.
A negative result does not absolutely exclude allergy when the clinical history is strongly suggestive.
Total IgE concentration, age, atopic disease, assay platform, and the interval since the last exposure may affect interpretation.
The concentration of oat-specific IgE does not reliably predict the severity of a future reaction.
An oral food challenge, performed under appropriate medical supervision, is the reference method for confirming or excluding clinical food allergy when the diagnosis remains uncertain.